A citation-based method for searching scientific literature

Hisko Oeseburg, Rudolf A de Boer, Hendrik Buikema, Pim van der Harst, Wiek H van Gilst, Herman H W Silljé. Arterioscler Thromb Vasc Biol 2010
Times Cited: 180







List of co-cited articles
645 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.
Zubair Shah, Thomas Kampfrath, Jeffrey A Deiuliis, Jixin Zhong, Colleen Pineda, Zhekang Ying, Xiaohua Xu, Bo Lu, Susan Moffatt-Bruce, Rekha Durairaj,[...]. Circulation 2011
268
3

Vascular endothelial senescence: from mechanisms to pathophysiology.
Jorge D Erusalimsky. J Appl Physiol (1985) 2009
247
3

Bradykinin protects against oxidative stress-induced endothelial cell senescence.
Hisko Oeseburg, Dilek Iusuf, Pim van der Harst, Wiek H van Gilst, Robert H Henning, Anton J M Roks. Hypertension 2009
69
4


Effect of a multifactorial intervention on mortality in type 2 diabetes.
Peter Gaede, Henrik Lund-Andersen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2008
3


Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
John A Dormandy, Bernard Charbonnel, David J A Eckland, Erland Erdmann, Massimo Massi-Benedetti, Ian K Moules, Allan M Skene, Meng H Tan, Pierre J Lefèbvre, Gordon D Murray,[...]. Lancet 2005
3

One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress.
Mathijs C Bunck, Anja Cornér, Bjorn Eliasson, Robert J Heine, Rimma M Shaginian, Yan Wu, Ping Yan, Ulf Smith, Hannele Yki-Järvinen, Michaela Diamant,[...]. Atherosclerosis 2010
88
3

Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.
Junichi Matsubara, Seigo Sugiyama, Eiichi Akiyama, Satomi Iwashita, Hirofumi Kurokawa, Keisuke Ohba, Hirofumi Maeda, Koichiro Fujisue, Eiichiro Yamamoto, Koichi Kaikita,[...]. Circ J 2013
145
3

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
712
3


Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
Eric A Schwartz, Juraj Koska, Michael P Mullin, Iyad Syoufi, Dawn C Schwenke, Peter D Reaven. Atherosclerosis 2010
130
3


Exenatide exerts a potent antiinflammatory effect.
Ajay Chaudhuri, Husam Ghanim, Mehul Vora, Chang Ling Sia, Kelly Korzeniewski, Sandeep Dhindsa, Antoine Makdissi, Paresh Dandona. J Clin Endocrinol Metab 2012
139
3

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.
M P Wautier, O Chappey, S Corda, D M Stern, A M Schmidt, J L Wautier. Am J Physiol Endocrinol Metab 2001
725
3

Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.
Nasib Ervinna, Tomoya Mita, Eisuke Yasunari, Kosuke Azuma, Rica Tanaka, Satoshi Fujimura, Dewi Sukmawati, Takashi Nomiyama, Akio Kanazawa, Ryuzo Kawamori,[...]. Endocrinology 2013
125
3

DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study.
Kazufumi Nakamura, Hiroki Oe, Hajime Kihara, Kenei Shimada, Shota Fukuda, Kyoko Watanabe, Tsutomu Takagi, Kei Yunoki, Toru Miyoshi, Kumiko Hirata,[...]. Cardiovasc Diabetol 2014
88
3

Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.
Y-S Lee, M-S Park, J-S Choung, S-S Kim, H-H Oh, C-S Choi, S-Y Ha, Y Kang, Y Kim, H-S Jun. Diabetologia 2012
135
3

Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice.
Cheol Whee Park, Hyeong Wook Kim, Seung Hyun Ko, Ji Hee Lim, Gyeong Ryul Ryu, Hyun Wha Chung, Sang Woo Han, Seog Jun Shin, Byung Kee Bang, Matthew D Breyer,[...]. J Am Soc Nephrol 2007
156
3

Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.
Vishal Patel, Amit Joharapurkar, Nirav Dhanesha, Samadhan Kshirsagar, Jaysukh Detroja, Kartikkumar Patel, Tejal Gandhi, Kirti Patel, Rajesh Bahekar, Mukul Jain. Pharmacol Rep 2013
19
15




Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.
R Kodera, K Shikata, H U Kataoka, T Takatsuka, S Miyamoto, M Sasaki, N Kajitani, S Nishishita, K Sarai, D Hirota,[...]. Diabetologia 2011
230
3


GLP-1 improves neuropathology after murine cold lesion brain trauma.
Brian DellaValle, Casper Hempel, Flemming Fryd Johansen, Jørgen Anders Lindholm Kurtzhals. Ann Clin Transl Neurol 2014
15
20


Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier.
Abba J Kastin, Victoria Akerstrom, Weihong Pan. J Mol Neurosci 2002
328
3

Cardiac function in mice lacking the glucagon-like peptide-1 receptor.
Robert Gros, Xiaomang You, Laurie L Baggio, M Golam Kabir, Al Muktafi Sadi, Imran N Mungrue, Thomas G Parker, Qingling Huang, Daniel J Drucker, Mansoor Husain. Endocrinology 2003
145
3

Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy.
Lazaros A Nikolaidis, Dariush Elahi, You-Tang Shen, Richard P Shannon. Am J Physiol Heart Circ Physiol 2005
205
3



Glucagon-like peptide-1 receptor is involved in learning and neuroprotection.
Matthew J During, Lei Cao, David S Zuzga, Jeremy S Francis, Helen L Fitzsimons, Xiangyang Jiao, Ross J Bland, Matthias Klugmann, William A Banks, Daniel J Drucker,[...]. Nat Med 2003
552
3

Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression.
Le Thi Kim Chung, Toshio Hosaka, Masaki Yoshida, Nagakatsu Harada, Hiroshi Sakaue, Tohru Sakai, Yutaka Nakaya. Biochem Biophys Res Commun 2009
91
3

GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
390
3



Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.
TracyAnn Perry, Debomoy K Lahiri, Kumar Sambamurti, Demao Chen, Mark P Mattson, Josephine M Egan, Nigel H Greig. J Neurosci Res 2003
265
3


Effects of glucagon-like peptide-1 receptor agonists on renal function.
Theodosios D Filippatos, Moses S Elisaf. World J Diabetes 2013
47
6

Acute renal failure in the medical intensive care unit: predisposing, complicating factors and outcome.
A B Groeneveld, D D Tran, J van der Meulen, J J Nauta, L G Thijs. Nephron 1991
237
3

Acute kidney injury associates with increased long-term mortality.
Jean-Philippe Lafrance, Donald R Miller. J Am Soc Nephrol 2010
357
3

Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies.
John W Pickering, Matthew T James, Suetonia C Palmer. Am J Kidney Dis 2015
129
3

Acute renal failure in the medical ICU still predictive of high mortality.
D V Friedericksen, L Van der Merwe, T L Hattingh, D G Nel, M R Moosa. S Afr Med J 2009
28
10

Adipose-derived mesenchymal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.
Yen-Ta Chen, Cheuk-Kwan Sun, Yu-Chun Lin, Li-Teh Chang, Yung-Lung Chen, Tzu-Hsien Tsai, Sheng-Ying Chung, Sarah Chua, Ying-Hsien Kao, Chia-Hong Yen,[...]. J Transl Med 2011
213
3

Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury.
Bing Li, Amy Cohen, Thomas E Hudson, Delara Motlagh, David L Amrani, Jeremy S Duffield. Circulation 2010
117
3

Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes.
Toshio Hayashi, Hisako Matsui-Hirai, Asaka Miyazaki-Akita, Akiko Fukatsu, Jun Funami, Qun-Fang Ding, Sumitra Kamalanathan, Yuichi Hattori, Louis J Ignarro, Akihisa Iguchi. Proc Natl Acad Sci U S A 2006
130
3

Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway.
Takeshige Kunieda, Tohru Minamino, Jun-Ichiro Nishi, Kaoru Tateno, Tomomi Oyama, Taro Katsuno, Hideyuki Miyauchi, Masayuki Orimo, Sho Okada, Masayuki Takamura,[...]. Circulation 2006
205
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.